Cargando…

Convalescent plasma to treat COVID-19: clinical experience and efficacy

The recent outbreak of COVID-19 in the world is currently a big threat to global health and economy. Convalescent plasma has been confirmed effective against the novel corona virus in preliminary studies. In this paper, we first described the therapeutic schedule, antibody detection method, indicati...

Descripción completa

Detalles Bibliográficos
Autores principales: Pei, Shiyao, Yuan, Xi, Zhang, Zhimin, Yao, Run, Xie, Yubin, Shen, Minxue, Li, Bijuan, Chen, Xiang, Yin, Mingzhu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8034927/
https://www.ncbi.nlm.nih.gov/pubmed/33735836
http://dx.doi.org/10.18632/aging.202795
_version_ 1783676621521158144
author Pei, Shiyao
Yuan, Xi
Zhang, Zhimin
Yao, Run
Xie, Yubin
Shen, Minxue
Li, Bijuan
Chen, Xiang
Yin, Mingzhu
author_facet Pei, Shiyao
Yuan, Xi
Zhang, Zhimin
Yao, Run
Xie, Yubin
Shen, Minxue
Li, Bijuan
Chen, Xiang
Yin, Mingzhu
author_sort Pei, Shiyao
collection PubMed
description The recent outbreak of COVID-19 in the world is currently a big threat to global health and economy. Convalescent plasma has been confirmed effective against the novel corona virus in preliminary studies. In this paper, we first described the therapeutic schedule, antibody detection method, indications, contraindications of the convalescent plasmas and reported the effectiveness of convalescent plasma therapy by a retrospective cohort study.
format Online
Article
Text
id pubmed-8034927
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Impact Journals
record_format MEDLINE/PubMed
spelling pubmed-80349272021-04-16 Convalescent plasma to treat COVID-19: clinical experience and efficacy Pei, Shiyao Yuan, Xi Zhang, Zhimin Yao, Run Xie, Yubin Shen, Minxue Li, Bijuan Chen, Xiang Yin, Mingzhu Aging (Albany NY) Research Paper The recent outbreak of COVID-19 in the world is currently a big threat to global health and economy. Convalescent plasma has been confirmed effective against the novel corona virus in preliminary studies. In this paper, we first described the therapeutic schedule, antibody detection method, indications, contraindications of the convalescent plasmas and reported the effectiveness of convalescent plasma therapy by a retrospective cohort study. Impact Journals 2021-03-18 /pmc/articles/PMC8034927/ /pubmed/33735836 http://dx.doi.org/10.18632/aging.202795 Text en Copyright: © 2021 Pei et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/3.0/) (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Paper
Pei, Shiyao
Yuan, Xi
Zhang, Zhimin
Yao, Run
Xie, Yubin
Shen, Minxue
Li, Bijuan
Chen, Xiang
Yin, Mingzhu
Convalescent plasma to treat COVID-19: clinical experience and efficacy
title Convalescent plasma to treat COVID-19: clinical experience and efficacy
title_full Convalescent plasma to treat COVID-19: clinical experience and efficacy
title_fullStr Convalescent plasma to treat COVID-19: clinical experience and efficacy
title_full_unstemmed Convalescent plasma to treat COVID-19: clinical experience and efficacy
title_short Convalescent plasma to treat COVID-19: clinical experience and efficacy
title_sort convalescent plasma to treat covid-19: clinical experience and efficacy
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8034927/
https://www.ncbi.nlm.nih.gov/pubmed/33735836
http://dx.doi.org/10.18632/aging.202795
work_keys_str_mv AT peishiyao convalescentplasmatotreatcovid19clinicalexperienceandefficacy
AT yuanxi convalescentplasmatotreatcovid19clinicalexperienceandefficacy
AT zhangzhimin convalescentplasmatotreatcovid19clinicalexperienceandefficacy
AT yaorun convalescentplasmatotreatcovid19clinicalexperienceandefficacy
AT xieyubin convalescentplasmatotreatcovid19clinicalexperienceandefficacy
AT shenminxue convalescentplasmatotreatcovid19clinicalexperienceandefficacy
AT libijuan convalescentplasmatotreatcovid19clinicalexperienceandefficacy
AT chenxiang convalescentplasmatotreatcovid19clinicalexperienceandefficacy
AT yinmingzhu convalescentplasmatotreatcovid19clinicalexperienceandefficacy